In a new study funded by the Macula Vision Research Foundation, University of Pennsylvania researchers report “encouraging” findings that mark the first clear step in developing a gene therapy that could prevent vision loss or even restore vision in individuals suffering from Best disease.  Click here to read the full press release from the University of Pennsylvania.